These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 3992472)

  • 1. Ocular drug bioavailability from topically applied liposomes.
    Lee VH; Urrea PT; Smith RE; Schanzlin DJ
    Surv Ophthalmol; 1985; 29(5):335-48. PubMed ID: 3992472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liposomes in topical ophthalmic drug delivery: an update.
    Agarwal R; Iezhitsa I; Agarwal P; Abdul Nasir NA; Razali N; Alyautdin R; Ismail NM
    Drug Deliv; 2016 May; 23(4):1075-91. PubMed ID: 25116511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Transcorneal drug delivery: prospects for the use of liposomes].
    Aliautdin RN; Iezhitsa IN; Agarval R
    Vestn Oftalmol; 2014; 130(4):117-22. PubMed ID: 25306734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Precorneal factors influencing the ocular distribution of topically applied liposomal inulin.
    Lee VH; Takemoto KA; Iimoto DS
    Curr Eye Res; 1984 Apr; 3(4):585-91. PubMed ID: 6713957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intraocular distribution of topically applied hydrophilic and lipophilic substances in rat eyes.
    Abdul Nasir NA; Agarwal P; Agarwal R; Iezhitsa I; Alyautdin R; Nukolova NN; Chekhonin VP; Mohd Ismail N
    Drug Deliv; 2016 Oct; 23(8):2765-2771. PubMed ID: 26289215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design principles of ocular drug delivery systems: importance of drug payload, release rate, and material properties.
    Subrizi A; Del Amo EM; Korzhikov-Vlakh V; Tennikova T; Ruponen M; Urtti A
    Drug Discov Today; 2019 Aug; 24(8):1446-1457. PubMed ID: 30738982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement of ocular drug penetration.
    Sasaki H; Yamamura K; Mukai T; Nishida K; Nakamura J; Nakashima M; Ichikawa M
    Crit Rev Ther Drug Carrier Syst; 1999; 16(1):85-146. PubMed ID: 10099899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liposomes as vehicles for topical ophthalmic drug delivery and ocular surface protection.
    López-Cano JJ; González-Cela-Casamayor MA; Andrés-Guerrero V; Herrero-Vanrell R; Molina-Martínez IT
    Expert Opin Drug Deliv; 2021 Jul; 18(7):819-847. PubMed ID: 33412914
    [No Abstract]   [Full Text] [Related]  

  • 9. Controlled and continuous release ocular drug delivery systems: pros and cons.
    Abdelkader H; Alany RG
    Curr Drug Deliv; 2012 Jul; 9(4):421-30. PubMed ID: 22640036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vesicular systems in ocular drug delivery: an overview.
    Kaur IP; Garg A; Singla AK; Aggarwal D
    Int J Pharm; 2004 Jan; 269(1):1-14. PubMed ID: 14698571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ocular disposition, pharmacokinetics, efficacy and safety of nanoparticle-formulated ophthalmic drugs.
    Bu HZ; Gukasyan HJ; Goulet L; Lou XJ; Xiang C; Koudriakova T
    Curr Drug Metab; 2007 Feb; 8(2):91-107. PubMed ID: 17305490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biopharmaceutical considerations in topical ocular drug delivery.
    Davies NM
    Clin Exp Pharmacol Physiol; 2000 Jul; 27(7):558-62. PubMed ID: 10874518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delivery of therapeutics for deep-seated ocular conditions - status quo.
    Nguyen H; Eng S; Ngo T; Dass CR
    J Pharm Pharmacol; 2018 Aug; 70(8):994-1001. PubMed ID: 29675844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanomaterials for ocular drug delivery.
    Liu S; Jones L; Gu FX
    Macromol Biosci; 2012 May; 12(5):608-20. PubMed ID: 22508445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acyclovir-containing liposomes for potential ocular delivery. Corneal penetration and absorption.
    Law SL; Huang KJ; Chiang CH
    J Control Release; 2000 Jan; 63(1-2):135-40. PubMed ID: 10640587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel micelle carriers for cyclosporin A topical ocular delivery: in vivo cornea penetration, ocular distribution and efficacy studies.
    Di Tommaso C; Bourges JL; Valamanesh F; Trubitsyn G; Torriglia A; Jeanny JC; Behar-Cohen F; Gurny R; Möller M
    Eur J Pharm Biopharm; 2012 Jun; 81(2):257-64. PubMed ID: 22445900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ocular pharmacokinetics of topically-applied ketoconazole solution containing hydroxypropyl beta-cyclodextrin to rabbits.
    Zhang J; Wang L; Gao C; Zhang L; Xia H
    J Ocul Pharmacol Ther; 2008 Oct; 24(5):501-6. PubMed ID: 18803444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenylboronic-Acid-Based Polymeric Micelles for Mucoadhesive Anterior Segment Ocular Drug Delivery.
    Prosperi-Porta G; Kedzior S; Muirhead B; Sheardown H
    Biomacromolecules; 2016 Apr; 17(4):1449-57. PubMed ID: 26963738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanistic modeling of ophthalmic drug delivery to the anterior chamber by eye drops and contact lenses.
    Gause S; Hsu KH; Shafor C; Dixon P; Powell KC; Chauhan A
    Adv Colloid Interface Sci; 2016 Jul; 233():139-154. PubMed ID: 26318359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Limits on optimizing ocular drug delivery.
    Keister JC; Cooper ER; Missel PJ; Lang JC; Hager DF
    J Pharm Sci; 1991 Jan; 80(1):50-3. PubMed ID: 2013850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.